Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Cellular Biochemistry
|
September 20, 2019
The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer
Zahra Zandi, Bahareh Kashani, Davood Bashash, et al.
Life Sciences
|
July 10, 2020
Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway
Ali Nasrollahzadeh, Davood Bashash, Majid Kabuli, et al.
Journal of Cancer Research and Clinical Oncology
|
January 4, 2022
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
Zahra Zandi, Bahareh Kashani, Zivar Alishahi, et al.
European Journal of Pharmacology
|
October 2, 2019
Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells
Sepideh Hamzehlou, Majid Momeny, Zahra Zandi, et al.
Clinical Case Reports
|
December 28, 2020
Visceral leishmaniasis in an adult case in Northeast of Iran: A case report and literature review
Mohammad Reza Taghavi, Samaneh Mollazadeh, Mohsen Seddigh-Shamsi, et al.
International Immunopharmacology
|
December 5, 2020
Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation
Sedigheh Baakhlagh, Bahareh Kashani, Zahra Zandi, et al.
BMC Women'S Health
|
November 1, 2024
Infertility treatments and risk of breast benign diseases: a case‒control study
Ashraf Moini, Sadaf Alipour, Zahra Zandi, et al.
Cancer Chemotherapy and Pharmacology
|
December 2, 2019
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)
Bahareh Kashani, Zahra Zandi, Davood Bashash, et al.
Small Methods
|
May 1, 2026
Large-Scale MXene Membrane Fabrication via Nonsolvent Phase Separation
Mostafa Dadashi Firouzjaei, Zahra Zandi, Hesam Jafarian, et al.
European Journal of Pharmacology
|
April 2, 2019
TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition
Zahra Zandi, Bahareh Kashani, Ensieh M Poursani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Cellular Biochemistry
|
September 20, 2019
The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer
Zahra Zandi, Bahareh Kashani, Davood Bashash, et al.
Life Sciences
|
July 10, 2020
Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway
Ali Nasrollahzadeh, Davood Bashash, Majid Kabuli, et al.
Journal of Cancer Research and Clinical Oncology
|
January 4, 2022
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
Zahra Zandi, Bahareh Kashani, Zivar Alishahi, et al.
European Journal of Pharmacology
|
October 2, 2019
Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells
Sepideh Hamzehlou, Majid Momeny, Zahra Zandi, et al.
Clinical Case Reports
|
December 28, 2020
Visceral leishmaniasis in an adult case in Northeast of Iran: A case report and literature review
Mohammad Reza Taghavi, Samaneh Mollazadeh, Mohsen Seddigh-Shamsi, et al.
International Immunopharmacology
|
December 5, 2020
Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation
Sedigheh Baakhlagh, Bahareh Kashani, Zahra Zandi, et al.
BMC Women'S Health
|
November 1, 2024
Infertility treatments and risk of breast benign diseases: a case‒control study
Ashraf Moini, Sadaf Alipour, Zahra Zandi, et al.
Cancer Chemotherapy and Pharmacology
|
December 2, 2019
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)
Bahareh Kashani, Zahra Zandi, Davood Bashash, et al.
Small Methods
|
May 1, 2026
Large-Scale MXene Membrane Fabrication via Nonsolvent Phase Separation
Mostafa Dadashi Firouzjaei, Zahra Zandi, Hesam Jafarian, et al.
European Journal of Pharmacology
|
April 2, 2019
TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition
Zahra Zandi, Bahareh Kashani, Ensieh M Poursani, et al.
Page
of 3